알림

Hims & Hers Health Inc. (HIMS)

NYSE: HIMS · 실시간 가격 · USD

33.78

+1.92 (6.03%)

종가 기준: Aug 21, 2026, 3:59 PM

33.80

+0.06%

애프터마켓: 7:59 PM

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

6.03% (1D)

매수호가	33.65
시가총액	7.88B
매출 (ttm)	2.58B
순이익 (ttm)	-142.03M
	2.42
	-0.64
	n/a
	30.32
P/B (ttm)	24.32
P/S (ttm)	3.06
실적 발표일	Nov 9, 2026

매도호가	34
거래량	14,654,414
평균 거래량 (20일)	16,222,943
시가	31.67
전일 종가	31.86
일중 범위	31.60 - 34.46
52주 범위	13.74 - 65.30
애널리스트	Hold
목표주가	30 (-11.19%)
배당	n/a
배당락일	n/a

HIMS 소개

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by...

섹터 Healthcare

IPO 일자 Sep 13, 2019

직원 수 2,442

상장 거래소 NYSE

티커 HIMS

웹사이트 https://www.hims.com

전체 기업 정보

재무 실적

2025년 Hims & Hers Health의 매출은 2.35B로, 전년 1.48B 대비 59% 증가했습니다. 순이익은 128.37M로, 1.85% 증가했습니다.

재무제표

애널리스트 전망

애널리스트 13명의 투자의견을 종합하면 HIMS 주식의 평균 등급은 "Hold"입니다. 12개월 목표주가는 30로, 최근 주가 대비 11.19% 하락 여력입니다.

주가 전망

어닝 서프라이즈

Hims & Hers Health가 Aug 10, 2026에 분기 실적을 발표했습니다:

매출 $608.1M 예상치 하회 $0, 및 3.77% 전년 대비 성장.
EPS -0.37 예상치 하회 -0.32, 및 -227.59% 전년 대비 감소.

다음 실적 발표

Hims & Hers Health Inc.의 실적 발표 예정일은 Nov 9, 2026, 정규장 중입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

8시간 전 · Simply Wall St.

Hims & Hers Health (HIMS) Faces Legal Pressure, Is The Stock Still Cheap?

Hims & Hers Health (HIMS) stock is back in focus after the Federal Trade Commission and state regulators filed a civil enforcement action, followed by a consumer class action targeting the company’s t...

14시간 전 · MT Newswires

Market Chatter: Hims & Hers Health Faces Nearly $75,000 Bill From Card Disputes

Hims & Hers Health (HIMS) was placed on notice by Visa for excessive customer complaints in its weig

22시간 전 · Zacks

HIMS Stock More Than Doubled in 6 Months: What's Driving the Rally?

Hims & Hers' rally is fueled by branded weight-loss growth, international expansion, AI efficiencies and a broader specialty portfolio.

1일 전 · Insider Monkey

Hims & Hers Health (HIMS) & Novo Nordisk A/S (NVO): Two Weight-Loss Pill Players Just Got Punished for Growing Fast

Hims & Hers Health, Inc. (NYSE:HIMS) shares fell over 2% on Tuesday even after the telehealth company posted second-quarter revenue of $753.2 million, up 38% and above the $699 million analysts expect...

1일 전 · Trefis

Hims & Hers Health Stock Trades Below The Market On Revenue And Above It On Cash

The gap between its revenue multiple and its cash multiple is margin, and the company is spending it on purpose.

2 페이지 중 1

Hims & Hers Health Inc. (HIMS)